Sign In
Buy EXEL
$51.60
+3.06 (+6.30%)
At Close: Jun 03, 2026
Exelixis, Inc. $EXEL Shares Acquired by Merit Financial Group LLC
05:28am, Monday, 20'th Apr 2026
Merit Financial Group LLC grew its holdings in Exelixis, Inc. (NASDAQ: EXEL) by 25.4% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exch
Here's Why Exelixis (EXEL) is a Strong Growth Stock
10:46am, Friday, 17'th Apr 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist
05:45pm, Thursday, 16'th Apr 2026
All three drugmakers have proven fairly innovative in their respective niches. Clinical and commercial progress could send their share prices soaring.
Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Thursday, 16'th Apr 2026
Exelixis (EXEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Exelixis: The Double Backbone Potential Of CABOMETYX And Zanzalintinib
12:27pm, Thursday, 16'th Apr 2026
Exelixis is positioned to evolve into a multi-franchise oncology company, anchored by CABOMETYX and the emerging zanzalintinib. CABOMETYX remains a durable cash generator, while zanzalintinib is expec
Exelixis: Stable Demand And High Margins With Undervalued Shares
03:59pm, Wednesday, 15'th Apr 2026
Exelixis is undervalued, trading at a discount to sector and historical multiples despite robust double-digit growth and operational excellence. EXEL maintains high margins, generates strong FCF, and
Here's Why Exelixis (EXEL) is a Strong Momentum Stock
10:50am, Wednesday, 15'th Apr 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
SG Americas Securities LLC Buys 15,203 Shares of Exelixis, Inc. $EXEL
05:05am, Tuesday, 07'th Apr 2026
SG Americas Securities LLC boosted its stake in Exelixis, Inc. (NASDAQ: EXEL) by 72.1% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange
Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?
10:40am, Friday, 03'rd Apr 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Exelixis (EXEL) is a Strong Growth Stock
10:46am, Wednesday, 01'st Apr 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Exelixis: A Strong Contender in the Cancer Drug Market
07:00pm, Tuesday, 31'st Mar 2026
Explore the exciting world of Exelixis (EXEL +2.24%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trend
Exelixis, Inc. (NASDAQ:EXEL) Receives Consensus Recommendation of “Hold” from Analysts
04:40am, Tuesday, 31'st Mar 2026
Shares of Exelixis, Inc. (NASDAQ: EXEL - Get Free Report) have earned an average recommendation of "Hold" from the twenty-three ratings firms that are covering the company, MarketBeat reports. Two res
Here's Why Exelixis (EXEL) is a Strong Value Stock
10:41am, Wednesday, 18'th Mar 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Best Healthcare Stocks to Buy With $50 Right Now
08:30am, Wednesday, 18'th Mar 2026
Pfizer and Novo Nordisk look cheap in more ways than one. Pipeline progress could help improve their financial results.
Center For Asset Management LLC Purchases New Shares in Exelixis, Inc. $EXEL
04:30am, Wednesday, 18'th Mar 2026
Center For Asset Management LLC acquired a new stake in shares of Exelixis, Inc. (NASDAQ: EXEL) during the undefined quarter, according to its most recent 13F filing with the SEC. The firm acquired 12
